These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Enhancement of the study on the relationship between hereditary hemorrhagic telangiectasia and disorders of blood vessel formation and development]. Zhang GS Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):177-8. PubMed ID: 15059528 [No Abstract] [Full Text] [Related]
4. What Benjamin Babington, William Osler, Frederick Weber, and Henri Rendu did not know. Hirschberg R Cardiovasc Res; 2005 Nov; 68(2):180-2. PubMed ID: 16198324 [No Abstract] [Full Text] [Related]
5. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. van den Driesche S; Mummery CL; Westermann CJ Cardiovasc Res; 2003 Apr; 58(1):20-31. PubMed ID: 12667943 [TBL] [Abstract][Full Text] [Related]
6. [Hereditary hemorrhagic telangiectasia]. Pérez del Molino A; Zarrabeitia R; Fernández A Med Clin (Barc); 2005 Apr; 124(15):583-7. PubMed ID: 15860174 [TBL] [Abstract][Full Text] [Related]
7. [Rendu-Osler disease: clinical and molecular update]. Bailly S; Dupuis-Girod S; Plauchu H Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677 [TBL] [Abstract][Full Text] [Related]
17. Rendu-Osler-Weber disease: update of medical and dental considerations. te Veldhuis EC; te Veldhuis AH; van Dijk FS; Kwee ML; van Hagen JM; Baart JA; van der Waal I Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):e38-41. PubMed ID: 18230376 [TBL] [Abstract][Full Text] [Related]
18. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379 [TBL] [Abstract][Full Text] [Related]
20. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]